| Stefania Carmona, MD | |
|
619 19th St S, Birmingham, AL 35233-1900 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | Stefania Carmona |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124525134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 38840 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy. UH is among the first hospitals in the United States and the only hospital in Northeast Ohio to use CCM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.
Is there a link between cell phones and brain tumors? Over the past 15 years, there has been growing concern about this possibility. Part of this concern stems from the fact that there are over one billion cell phone subscribers worldwide, and the number is increasing.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL Single-dose Vials.
› Verified 5 days ago
| Entity Name | University Of Alabama At Birmingham |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184738478 PECOS PAC ID: 3779487970 Enrollment ID: O20031120000323 |
News Archive
A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy. UH is among the first hospitals in the United States and the only hospital in Northeast Ohio to use CCM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.
Is there a link between cell phones and brain tumors? Over the past 15 years, there has been growing concern about this possibility. Part of this concern stems from the fact that there are over one billion cell phone subscribers worldwide, and the number is increasing.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL Single-dose Vials.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stefania Carmona, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Stefania Carmona, MD 619 19th St S, Birmingham, AL 35233-1900 Ph: (205) 934-4011 |
News Archive
A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy. UH is among the first hospitals in the United States and the only hospital in Northeast Ohio to use CCM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclonal antibody (MAb) biosimilars have entered into an agreement for the co-development of a biosimilar version of the TNF inhibitor MAb Adalimumab.
Is there a link between cell phones and brain tumors? Over the past 15 years, there has been growing concern about this possibility. Part of this concern stems from the fact that there are over one billion cell phone subscribers worldwide, and the number is increasing.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL Single-dose Vials.
› Verified 5 days ago
Juan Mario Bernal, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Infectious Disease Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |